Ducentis BioTherapeutics - Ownership and Business Overview

Life ScienceCompany

Ducentis BioTherapeutics Ownership

Who owns Ducentis BioTherapeutics?

Ducentis BioTherapeutics is owned by Arcutis Biotherapeutics. It was acquired on September 7, 2022.

Ducentis BioTherapeutics Business Overview

Where is Ducentis BioTherapeutics headquartered?

Ducentis BioTherapeutics is headquartered in Oxfordshire, United Kingdom.

What sector is Ducentis BioTherapeutics in?

Ducentis BioTherapeutics is a life science company.

When was Ducentis BioTherapeutics founded?

Ducentis BioTherapeutics was founded in 2015.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.

Ducentis BioTherapeutics

Ducentis BioTherapeutics Ltd.

264 Banbury Road, Oxford,
Oxfordshire, OX2 7DY
United Kingdom,
www.ducentisbio.com

Ducentis BioTherapeutics is a pre-clinical stage biotech company aiming to develop novel therapies for autoimmune disease patients with poor treatment options. Ducentis BioTherapeutics was founded in 2015 and is based in Oxfordshire, United Kingdom.


 Subscribe to unlock this and 207,673
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Ducentis BioTherapeutics

Life Science Companies , United Kingdom Companies